PureTech Health plc (LON:PRTC – Get Free Report) rose 14.2% during trading on Saturday . The stock traded as high as GBX 123.80 ($1.67) and last traded at GBX 121.50 ($1.64). Approximately 9,013,305 shares were traded during trading, an increase of 1,053% from the average daily volume of 781,543 shares. The stock had previously closed at GBX 106.40 ($1.43).
PureTech Health Stock Performance
The firm has a market capitalization of £291.95 million, a PE ratio of 710.59 and a beta of 1.02. The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51. The company’s fifty day simple moving average is GBX 129.46 and its 200 day simple moving average is GBX 129.72.
Insider Buying and Selling
In other PureTech Health news, insider Bharatt Chowrira acquired 167,739 shares of the company’s stock in a transaction on Thursday, July 3rd. The shares were acquired at an average cost of GBX 1 per share, with a total value of £1,677.39. 13.13% of the stock is currently owned by company insiders.
About PureTech Health
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
See Also
- Five stocks we like better than PureTech Health
- Investing in the High PE Growth Stocks
- 3 Overlooked Value Stocks Set to Surge as Rates Drop
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy
- Bank Stocks – Best Bank Stocks to Invest In
- After the Fed’s Rate Cut, PNC Could See a Mortgage Refinance Boom
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
